Christina Lill is Heisenberg Professor of Translational Epidemiology at the Institute of Epidemiology and Social Medicine at University of Münster, Germany and lecturer at the School of Public Health at Imperial College London, United Kingdom. She is a medical doctor  and an epidemiologist. Her expertise lies in the molecular epidemiology of complex diseases, predominantly Alzheimer’s disease (AD) and Parkinson’s disease (PD) and other neurodegenerative diseases, as well as quantitative aging phenotypes. Lill's current projects include epigenome-wide, transcriptomic and proteomic analyses of pre-disease AD, PD, and ALS blood samples and the development of risk prediction models and optimization of molecular clocks based on these multi-dimensional data.